Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marc Braunstein is active.

Publication


Featured researches published by Marc Braunstein.


Journal of Oncology | 2011

Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101

Marc Braunstein; Sadeaqua Scott; Craig M. Scott; Shannon Behrman; Peter Walter; Peter Wipf; Jeremy D. Coplan; William Chrico; Danielle Joseph; Jeffrey L. Brodsky; Olcay Batuman

Multiple myeloma (MM) is the second most common hematologic malignancy and remains incurable, primarily due to the treatment-refractory/resistant nature of the disease. A rational approach to this compelling challenge is to develop new drugs that act synergistically with existing effective agents. This approach will reduce drug concentrations, avoid treatment resistance, and also improve treatment effectiveness by targeting new and nonredundant pathways in MM. Toward this goal, we examined the antimyeloma effects of MAL3-101, a member of a new class of non-ATP-site inhibitors of the heat shock protein (Hsp) 70 molecular chaperone. We discovered that MAL3-101 exhibited antimyeloma effects on MM cell lines in vitro and in vivo in a xenograft plasmacytoma model, as well as on primary tumor cells and bone marrow endothelial cells from myeloma patients. In combination with a proteasome inhibitor, MAL3-101 significantly potentiated the in vitro and in vivo antimyeloma effects. These data support a preclinical rationale for small molecule inhibition of Hsp70 function, either alone or in combination with other agents, as an effective therapeutic strategy for MM.


The Journal of Allergy and Clinical Immunology | 2015

Association between climate factors, pollen counts, and childhood hay fever prevalence in the United States

Jonathan I. Silverberg; Marc Braunstein; Mary Lee-Wong

BACKGROUND Climate factors and pollen counts may play a role in hay fever. OBJECTIVE We sought to determine the impact of specific climate factors and pollen counts on the US prevalence of hay fever and statewide variation in prevalence. METHODS We used a merged analysis of the 2007 National Survey of Childrens Health from a representative sample of 91,642 children aged 0 to 17 years and the 2006-2007 National Climate Data Center and Weather Service measurements of relative humidity (%), indoor heating degree days, precipitation, Palmer Hydrological Drought Index, clear sky and issued ultraviolet indices, stratospheric ozone levels, and outdoor air temperature and National Allergy Bureau total pollen counts. Multivariate survey logistic regression models controlled for sex, race/ethnicity, age, household income, and birthplace. RESULTS The US prevalence of hay fever in childhood was 18.0% (95% CI, 17.7% to 18.2%), with the highest prevalence in southeastern and southern states. Hay fever prevalence was significantly lower with second and third quartile mean annual relative humidity (logistic regression, P ≤ .01 for both), fourth quartile mean annual Palmer Hydrological Drought Index (P = .02), third and fourth quartile mean annual heating degree days (P < .0001 for both), and third and fourth quartile mean annual stratospheric ozone levels but increased with second, third, and fourth quartile mean annual temperature (P ≤ .02 for both), fourth quartile mean annual precipitation (P = .0007), mean total pollen counts (P = .01), and second, third, and fourth quartile issued ultraviolet index (P ≤ .0001 for all). Principal-component analysis was also used to determine the combined effects of correlated climate variables and pollen counts. CONCLUSIONS This study provides evidence of the influence of climate on the US prevalence of childhood hay fever.


BMC Cancer | 2006

Endothelial progenitor cells display clonal restriction in multiple myeloma

Marc Braunstein; Tayfun Ozcelik; Sevgi Bagislar; Varsha Vakil; Eric L.P. Smith; Kezhi Dai; Cemaliye Boylu Akyerli; Olcay Batuman

BackgroundIn multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to understand the mechanisms responsible for increased EPC levels and neoangiogenic function in MM, we investigated whether these cells were clonal by determining X-chromosome inactivation (XCI) patterns in female patients by a human androgen receptor assay (HUMARA). In addition, EPCs and bone marrow cells were studied for the presence of clonotypic immunoglobulin heavy-chain (IGH) gene rearrangement, which indicates clonality in B cells; thus, its presence in EPCs would indicate a close genetic link between tumor cells in MM and endothelial cells that provide tumor neovascularization.MethodsA total of twenty-three consecutive patients who had not received chemotherapy were studied. Screening in 18 patients found that 11 displayed allelic AR in peripheral blood mononuclear cells, and these patients were further studied for XCI patterns in EPCs and hair root cells by HUMARA. In 2 patients whose EPCs were clonal by HUMARA, and in an additional 5 new patients, EPCs were studied for IGH gene rearrangement using PCR with family-specific primers for IGH variable genes (VH).ResultsIn 11 patients, analysis of EPCs by HUMARA revealed significant skewing (≥ 77% expression of a single allele) in 64% (n = 7). In 4 of these patients, XCI skewing was extreme (≥ 90% expression of a single allele). In contrast, XCI in hair root cells was random. Furthermore, PCR amplification with VH primers resulted in amplification of the same product in EPCs and bone marrow cells in 71% (n = 5) of 7 patients, while no IGH rearrangement was found in EPCs from healthy controls. In addition, in patients with XCI skewing in EPCs, advanced age was associated with poorer clinical status, unlike patients whose EPCs had random XCI.ConclusionOur results suggest that EPCs in at least a substantial subpopulation of MM patients are related to the neoplastic clone and that this is an important mechanism for upregulation of tumor neovascularization in MM.


Blood | 2005

Circulating endothelial progenitor cells in multiple myeloma: implications and significance

Hong Zhang; Varsha Vakil; Marc Braunstein; Eric P. Smith; Justin Maroney; Laurie Chen; Kezhi Dai; James R. Berenson; M. Mahmood Hussain; Uwe Klueppelberg; Allen J. Norin; Hasan O. Akman; Tayfun Ozcelik; Olcay Batuman


/data/revues/00916749/unassign/S0091674914011154/ | 2014

Association between climate factors, pollen counts, and childhood hay fever prevalence in the US

Jonathan I. Silverberg; Marc Braunstein


Blood | 2010

Genomic Analysis of Endothelial Progenitor Cells In Multiple Myeloma Reveals Aberrant Gene Pathways Common to Tumor Cells

Marc Braunstein; Sadeaqua Scott; Eric L.P. Smith; Danielle Joseph; Jason Gonsky; Ruben D. Carrasco; Kumar Sukhdeo; Alexei Protopopov; Kenneth C. Anderson; Olcay Batuman


Blood | 2010

Junctional Adhesion Molecule-A/F11 Receptor (JAM-A/F11R) Is a Novel Biomarker and a Potential Treatment Target In Multiple Myeloma Tumor and Its Microvascular Milieu

Bani M Azari; Danielle Joseph; Marc Braunstein; H. Uwe Klueppelberg; Eric L.P. Smith; Sadeaqua Scott; Jonathan D. Marmur; Anna Babinska; Olcay Batuman


Blood | 2009

Junctional Adhesion Molecule-A/ F11 Receptor (JAM-A/ F11R) Expression in Multiple Myeloma (MM): a Candidate Biomarker of Aggressive Disease.

Bani M Azari; Marc Braunstein; H. Uwe Kluppelberg; Sadeaqua Scott; Eric L.P. Smith; Jonathan D. Marmur; Anna Babinska; Olcay Batuman


Blood | 2009

Endothelial Progenitor Cells within the Bone Marrow Microenvironment of Multiple Myeloma Patients Display Stem Cell Traits.

Sadeaqua Scott; Marc Braunstein; Christopher S. Lange; Christopher Roman; Uwe Klueppelberg; Olcay Batuman


Cancer Epidemiology and Prevention Biomarkers | 2007

Treatment of multiple myeloma with thalidomide, dexamethasone, and zoledronate in an inner-city population with high prevalence of HIV/AIDS

Uwe Klueppelberg; Eric L.P. Smith; Marc Braunstein; Olcay Batuman

Collaboration


Dive into the Marc Braunstein's collaboration.

Top Co-Authors

Avatar

Olcay Batuman

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Eric L.P. Smith

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Uwe Klueppelberg

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Sadeaqua Scott

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Varsha Vakil

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Alexei Protopopov

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

Craig M. Scott

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar

Danielle Joseph

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar

David Kahn

SUNY Downstate Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge